, Clinical Epidemiology and Global Health, Volume 11, 1 July 2021
Background: The coronavirus pandemic (COVID-19) has a social and psychological impact among healthcare workers worldwide and appropriate coping strategies are essential to avoid the negative mental health effects. This study aimed to investigate the coping strategies among the healthcare workers from different countries and their attitude towards teamwork during the COVID-19 pandemic. Methods: A cross-sectional study was conducted by using an online, web-based questionnaire, which was distributed to healthcare workers from 32 countries during April and May 2020.
, Advances in Child Development and Behavior, Volume 60, January 2021
Research conducted over the last century has suggested a role for sleep in the processes guiding healthy cognition and development, including memory consolidation. Children with intellectual and developmental disabilities (IDDs) tend to have higher rates of sleep disturbances, which could relate to behavior issues, developmental delays, and learning difficulties.
, Building and Environment, Volume 150, March 2019
Dementia can disturb the circadian rhythm more than in normal ageing people. And their biological clock is often not enough stimulated by light. Sleep disturbances form a high burden for informal caregivers and is the main reason for institutionalization. The effect of biodynamic lighting with varying intensity and colour resembling a daylight curve has hardly been objectively researched. In this study, we evaluate the exposure to biodynamic lighting on circadian functioning of 13 patients with dementia admitted to a psychiatric hospital.
, Neurobiology of Stress, Volume 10, February 2019
The Alzheimer's disease (AD) was discovered and the pathological hallmarks were revealed more than a century ago. Subsequently, many remarkable discoveries and breakthroughs provided us with mechanistic insights into the pathogenesis of AD. The identification of the molecular underpinning of the disease not only provided the framework of AD pathogenesis but also targets for therapeutic inventions. Despite all the initial successes, no effective treatment for AD has emerged yet as all the late stage of clinical trials have failed.